Évaluation et prise en charge du risque fongique chez le patient atteint de mucoviscidose : résultats de la phase d'inclusion de l'étude Mucofong au CHU de Grenoble

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  2009-06-15

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review.

  2009cited by this paper
• Prevalence of Community-Associated Methicillin-Resistant Staphylococcus aureus in Patients with Cystic Fibrosis

  2009cited by this paper
• Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions.

  2009influential reference
• Molecular typing and colonization patterns of Aspergillus fumigatus in patients with cystic fibrosis.

  2009cited by this paper
• Immunological mechanisms behind the cystic fibrosis-ABPA link.

  2009influential reference
• Omalizumab for exacerbations of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

  2009cited by this paper
• Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.

  2009cited by this paper
• Modulation of Toll-Like Receptor 2 (TLR2) and TLR4 Responses by Aspergillus fumigatus

  2009cited by this paper
• Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study.

  2009cited by this paper
• Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins

  2008cited by this paper
• Partial correction of the CFTR‐dependent ABPA mouse model with recombinant adeno‐associated virus gene transfer of truncated CFTR gene

  2008cited by this paper
• In Vitro Activities of 35 Double Combinations of Antifungal Agents against Scedosporium apiospermum and Scedosporium prolificans

  2008cited by this paper
• Genetic Adaptation of Pseudomonas aeruginosa to the Airways of Cystic Fibrosis Patients Is Catalyzed by Hypermutation

  2008cited by this paper
• Aspergillus/Allergic Bronchopulmonary Aspergillosis in an Irish Cystic Fibrosis Population: A Diagnostically Challenging Entity

  2008cited by this paper
• [Aspergillus fumigatus and Candida albicans in cystic fibrosis: clinical significance and specific immune response involving serum immunoglobulins G, A, and M].

  2008cited by this paper
• Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient.

  2008cited by this paper
• Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA?

  2008cited by this paper
• Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis

  2008influential reference
• Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti‐IgE antibody (omalizumab)

  2008cited by this paper
• Development of a novel PCR assay for the identification of the black yeast, Exophiala (Wangiella) dermatitidis from adult patients with cystic fibrosis (CF).

  2008cited by this paper
• Development of selective media for the isolation of yeasts and filamentous fungi from the sputum of adult patients with cystic fibrosis (CF).

  2008cited by this paper
• Development of an Oligonucleotide Array for Direct Detection of Fungi in Sputum Samples from Patients with Cystic Fibrosis

  2008cited by this paper
• Serologic diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis through the detection of immunoglobulin G to Aspergillus fumigatus.

  2008cited by this paper
• Efficacy of a selective isolation procedure for members of the Pseudallescheria boydii complex

  2008cited by this paper
• Susceptibility Testing of Anidulafungin and Voriconazole Alone and in Combination against Conidia and Hyphae of Aspergillus spp. under Hypoxic Conditions

  2008cited by this paper
• Steroid‐sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis

  2008cited by this paper
• Aspergillus Section Fumigati: Antifungal Susceptibility Patterns and Sequence-Based Identification

  2008cited by this paper
• Infections Caused by Scedosporium spp

  2008cited by this paper
• Allergic bronchopulmonary aspergillosis' diagnosis remains a challenge.

  2007cited by this paper
• Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody

  2007cited by this paper
• A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients.

  2007cited by this paper
• Potential role of the cellular allergen stimulation test (CAST) in diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis

  2007cited by this paper
• Factors effecting impact of Aspergillus fumigatus sensitization in cystic fibrosis

  2007cited by this paper
• HLA-DRB1 alleles control allergic bronchopulmonary aspergillosis-like pulmonary responses in humanized transgenic mice.

  2007influential reference
• Role of chest radiography in the diagnosis of allergic bronchopulmonary aspergillosis in adult patients with cystic fibrosis

  2007cited by this paper
• Specific IgE against recombinant allergens in allergic bronchopulmonary aspergillosis.

  2007cited by this paper
• Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis

  2006influential reference
• Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

  2006cited by this paper
• Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial

  2006cited by this paper
• Aspergillus fumigatus Generates an Enhanced Th2-Biased Immune Response in Mice with Defective Cystic Fibrosis Transmembrane Conductance Regulator1

  2006cited by this paper
• Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis

  2006cited by this paper
• Evaluation of peptone glucose fluconazole agar as a selective medium for rapid and enhanced isolation of Aspergillus fumigatus from the respiratory tract of bronchopulmonary aspergillosis patients colonized by Candida albicans.

  2006influential reference
• Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA

  2006cited by this paper
• Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis.

  2006cited by this paper
• Enhanced IgE allergic response to Aspergillus fumigatus in CFTR−/− mice

  2006cited by this paper
• Pulse Intravenous Methylprednisolone for Resistant Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis

  2006cited by this paper
• ABPA diagnosis in cystic fibrosis patients: the clinical utility of IgE specific to recombinant Aspergillus fumigatus allergens.

  2006cited by this paper
• Aspergillus bronchitis in cystic fibrosis.

  2006influential reference
• Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis.

  2006influential reference
• [Semi-invasive necrotic aspergillosis in a child with cystic fibrosis].

  2006cited by this paper
• Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation.

  2006cited by this paper
• Endobronchitis by Scedosporium apiospermum in a child with cystic fibrosis.

  2006cited by this paper
• Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy.

  2005cited by this paper
• Aspergillus antigens: which are important?

  2005cited by this paper
• Allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis: diagnostic criteria when the IgE level is less than 500 IU/mL.

  2005cited by this paper
• [Aspergillus bronchitis and aspergilloma treated successfully with voriconazole].

  2005cited by this paper
• Voriconazole therapy in children with cystic fibrosis.

  2005cited by this paper
• Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA

  2005cited by this paper
• Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy

  2005cited by this paper
• Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis.

  2005cited by this paper
• Airway Colonization by Acrophialophora fusispora in Patients with Cystic Fibrosis

  2005cited by this paper
• Life‐threatening allergic bronchopulmonary aspergillosis in a well child with cystic fibrosis

  2005cited by this paper
• Increased sensitivity to IL-4 in cystic fibrosis patients with allergic bronchopulmonary aspergillosis.

  2004influential reference
• Isolation of Fungi, Especially Exophiala dermatitidis, in Patients Suffering from Cystic Fibrosis

  2004cited by this paper
• Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis.

  2004cited by this paper
• Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment.

  2004cited by this paper
• Allergic bronchopulmonary aspergillosis in Italian cystic fibrosis patients: Prevalence and percentage of positive tests in the employed diagnostic criteria

  2004cited by this paper
• IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis

  2004cited by this paper
• In Vitro Testing of Aspergillus fumigatus Clinical Isolates for Susceptibility to Voriconazole, Amphotericin B and Itraconazole: Comparison of Sensititre versus NCCLS M38-A Using Two Different Inocula

  2004cited by this paper
• Aspergillus terreus in a cystic fibrosis clinic: environmental distribution and patient colonization pattern.

  2003cited by this paper
• The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema

  2003influential reference
• Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis

  2003influential reference
• Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis

  2003cited by this paper
• Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial.

  2003cited by this paper
• Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference.

  2003influential reference
• Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis.

  2003cited by this paper
• Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis.

  2003cited by this paper
• Exhaled nitric oxide in cystic fibrosis patients with allergic bronchopulmonary aspergillosis.

  2003cited by this paper
• IL-10 Controls Aspergillus fumigatus- and Pseudomonas aeruginosa-Specific T-Cell Response in Cystic Fibrosis

  2003cited by this paper
• Mild, moderate, and severe forms of allergic bronchopulmonary aspergillosis: a clinical and serologic evaluation.

  2003influential reference
• Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis

  2003influential reference
• Serologic IgE immune responses against Aspergillus fumigatus and Candida albicans in patients with cystic fibrosis.

  2002cited by this paper
• Genotyping Study of Scedosporium apiospermum Isolates from Patients with Cystic Fibrosis

  2002cited by this paper
• Intracutaneous tests with recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus allergy.

  2002cited by this paper
• Molecular epidemiology of airway colonisation by Aspergillus fumigatus in cystic fibrosis patients.

  2001cited by this paper
• [Bronchopulmonary aspergillosis: new developments].

  2001cited by this paper
• The pathobiology of Aspergillus fumigatus.

  2001influential reference
• Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis.

  2001influential reference
• Increased Sensitivity to IL-4 in Patients with Allergic Bronchopulmonary Aspergillosis

  2000cited by this paper
• Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study

  2000influential reference
• Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis

  2000influential reference
• Clinical Significance of Scedosporium apiospermum in Patients with Cystic Fibrosis

  2000influential reference
• A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.

  2000cited by this paper
• Systemic activation of basophils and eosinophils: markers and consequences.

  2000influential reference
• Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis.

  2000cited by this paper
• Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis.

  1999cited by this paper
• Determinants of chronic infection with Staphylococcus aureus in patients with bronchiectasis.

  1999cited by this paper
• Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients.

  1999cited by this paper
• Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis.

  1999cited by this paper
• Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth.

  1999cited by this paper

• No citing papers are available for this paper.